BeOne Medicines AG (ONC)
NASDAQ: ONC · Real-Time Price · USD
301.54
+0.74 (0.25%)
Apr 27, 2026, 12:00 PM EDT - Market open
BeOne Medicines AG Employees
BeOne Medicines AG had 12,000 employees as of December 31, 2025. The number of employees increased by 1,000 or 9.09% compared to the previous year.
Employees
12,000
Change
1,000
Growth
9.09%
Revenue / Employee
$445,253
Profits / Employee
$23,911
Market Cap
33.44B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 12,000 | 1,000 | 9.09% | 12,000 | 0 |
| Sep 30, 2025 | 11,000 | 1,000 | 10.00% | 11,000 | 0 |
| Jun 30, 2025 | 11,000 | 1,000 | 10.00% | 11,000 | 0 |
| Mar 31, 2025 | 11,000 | 1,000 | 10.00% | 11,000 | 0 |
| Dec 31, 2024 | 11,000 | 400 | 3.77% | 11,000 | 0 |
| Jun 30, 2024 | 10,000 | 600 | 6.38% | 10,000 | 0 |
| Mar 31, 2024 | 10,000 | 600 | 6.38% | 10,000 | 0 |
| Dec 31, 2023 | 10,600 | 1,600 | 17.78% | 10,600 | 0 |
| Mar 31, 2023 | 9,400 | 1,100 | 13.25% | 9,400 | 0 |
| Dec 31, 2022 | 9,000 | 1,000 | 12.50% | 9,000 | 0 |
| Sep 30, 2022 | 9,000 | 1,400 | 18.42% | 9,000 | 0 |
| Mar 31, 2022 | 8,300 | 2,900 | 53.70% | 8,300 | 0 |
| Dec 31, 2021 | 8,000 | 2,700 | 50.94% | 8,000 | 0 |
| Sep 30, 2021 | 7,600 | 3,000 | 65.22% | 7,600 | 0 |
| Mar 31, 2021 | 5,400 | 1,800 | 50.00% | 5,400 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| BioNTech SE | 7,807 |
| Moderna | 4,700 |
| Genmab | 2,973 |
| Incyte | 2,844 |
| Alnylam Pharmaceuticals | 2,500 |
| argenx SE | 1,863 |
| Insmed | 1,664 |
| Revolution Medicines | 883 |
ONC News
- 5 days ago - BeOne Medicines to Announce First Quarter 2026 Financial Results on May 6 - Business Wire
- 5 days ago - Baker Bros. Advisors LP's Strategic Acquisition of BeOne Medicines Ltd Shares - GuruFocus
- 7 days ago - BeiGene Acquires Exclusive Rights for Fizepizumab in Greater China - GuruFocus
- 12 days ago - BeiGene (ONC) Prepares for Q1 Earnings Announcement with Strong Track Record - GuruFocus
- 17 days ago - BeOne Medicines (ONC) Receives Conditional Approval for Lung Cancer Treatment - GuruFocus
- 4 weeks ago - If You Invested $100 In BeOne Medicines Stock 10 Years Ago, You Would Have This Much Today - Benzinga
- 6 weeks ago - ONC: Jefferies Downgrades BeOne Medicines to Hold, Lowers Price Target | ONC Stock News - GuruFocus
- 7 weeks ago - BeOne Medicines Ltd (ONC) Q4 2025 Earnings Call Highlights: Record Growth and Strategic Expansion - GuruFocus